Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer - Report - MDSpire

Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer

  • By

  • Agata Świętek

  • Joanna K. Strzelczyk

  • Dorota Hudy

  • Zenon P. Czuba

  • Karolina Snopek-Miśta

  • Mariusz Kryj

  • Katarzyna Kuśnierz

  • Marcin Zeman

  • Malgorzata Oczko-Wojciechowska

  • Daria Handkiewicz-Junak

  • Janusz Strzelczyk

  • July 2, 2026

  • 0 min

Share

Significant Impact of IL-6, IL-8, IL-11, and Leptin on Tumor Microenvironment

Overview

This study reports elevated levels of IL-6, IL-8, IL-11, and leptin in tumor tissues of patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) compared to surgical margins.

Background

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a diverse group of rare cancers that have seen an increase in incidence due to better diagnostic methods. Understanding the cytokine profiles in GEP-NETs is crucial as they may influence tumor behavior.

Data Highlights

CytokineSample TypeConcentration
IL-6TumorHigher
IL-8TumorHigher
IL-11TumorHigher
LeptinTumorHigher

Key Findings

  • Higher concentrations of IL-6, IL-8, IL-11, and leptin were found in tumor samples compared to surgical margins.
  • IL-6 and leptin levels were elevated in tumors and margins from patients with T4 stage.
  • Tumor leptin levels were increased in patients with N2 compared to N0.
  • Margin IL-11 concentration was higher in N0 compared with N2.
  • IL-6 and leptin levels were higher in patients with M1 compared to M0.
  • Cytokine levels varied according to tumor localization, with differences noted among pancreatic, ileal, colonic, and small intestine tumors.

Clinical Implications

Cytokine levels in GEP-NETs may correlate with tumor behavior and clinical factors.

Conclusion

The study provides evidence of altered cytokine expression in GEP-NET tissues compared to surgical margins.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Cytokine and chemokine networks in colorectal cancer
  2. The ASCO Post, 2014 -- IL-17A Promotes and GM-CSF Suppresses Circulating Tumor Cells and Metastasis in Colorectal Cancer
  3. Journal of Gastroenterology, 2013 -- Understanding Cancer Cachexia: Mechanisms and Treatment Approaches
  4. European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours
  5. Gastric Cancer — The Role of EMILIN-1 in Modulating the Tumor Microenvironment and Inhibiting Gastric Cancer Development and Progression
  6. NETTER-2 Lu-177 Dotatate for Advanced Gastroenteropancreatic Neuroendocrine Tumors - The ASCO Post
  7. European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours
  8. Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs - PubMed

Original Source(s)

Related Content